Ratings by Oppenheimer (Francois Brisebois)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/30/2021 icad Inc. ICAD Maintain Outperform
(N/A)
 
 
  Details
8/12/2021 DiaMedica Therapeutics Inc. DMAC Maintain Outperform
(N/A)
 
 
  Details
8/6/2021 Kala Pharmaceuticals KALA Maintain Outperform
(N/A)
 
 
  Details
8/3/2021 Processa Pharmaceuticals PCSA New Coverage Outperform
(N/A)
5.98
(7.91)
32.27% Details
7/30/2021 Durect Corp DRRX Maintain Outperform
(N/A)
 
 
  Details
7/13/2021 Simulations Plus SLP Maintain Outperform
(N/A)
 
 
  Details
6/23/2021 Achieve Life Sciences ACHV New Coverage Outperform
(N/A)
7.93
(8.28)
4.41% Details
5/24/2021 Savara SVRA Maintain Outperform
(N/A)
 
 
  Details
4/9/2021 DiaMedica Therapeutics Inc. DMAC New Coverage Outperform
(N/A)
9.35
(4.18)
-55.29% Details
4/6/2021 icad Inc. ICAD Maintain Outperform
(N/A)
 
 
  Details
3/16/2021 icad Inc. ICAD Maintain Outperform
(N/A)
 
 
  Details
3/15/2021 Savara SVRA New Coverage Outperform
(N/A)
1.57
(1.39)
-11.46% Details
2/26/2021 Aerie Pharma AERI Maintain Outperform
(N/A)
 
 
  Details
2/26/2021 icad Inc. ICAD New Coverage Outperform
(N/A)
18.06
(10.44)
-42.19% Details
2/22/2021 Otonomy OTIC Maintain Outperform
(N/A)
 
 
  Details
2/2/2021 Durect Corp DRRX Maintain Outperform
(N/A)
 
 
  Details
1/14/2021 Flexion Therapeutics FLXN Maintain Outperform
(N/A)
 
 
  Details
1/12/2021 Simulations Plus SLP Maintain Outperform
(N/A)
 
 
  Details
12/18/2020 Otonomy OTIC Maintain Outperform
(N/A)
 
 
  Details
11/23/2020 Otonomy OTIC Maintain Outperform
(N/A)
 
 
  Details
10/27/2020 Kala Pharmaceuticals KALA Maintain Outperform
(N/A)
 
 
  Details
9/8/2020 Simulations Plus SLP New Coverage Outperform
(N/A)
59.97
(43.70)
-27.13% Details
8/7/2020 Pfenex Inc. PFNX Maintain Outperform
(N/A)
 
 
  Details
7/31/2020 Avadel Pharmaceuticals AVDL New Coverage Outperform
(N/A)
8.20
(7.95)
-3.05% Details
7/31/2020 Durect Corp DRRX New Coverage Outperform
(N/A)
1.97
(1.31)
-33.5% Details
7/31/2020 Flexion Therapeutics FLXN New Coverage Outperform
(N/A)
13.52
(6.23)
-53.92% Details
7/7/2020 Otonomy OTIC Maintain Outperform
(N/A)
 
 
  Details
6/23/2020 Pfenex Inc. PFNX Maintain Outperform
(N/A)
 
 
  Details
6/15/2020 Pfenex Inc. PFNX Maintain Outperform
(Outperform)
 
 
  Details
6/1/2020 Pfenex Inc. PFNX New Coverage Outperform
(N/A)
7.31
(12.75)
74.42% Details
6/1/2020 Otonomy OTIC New Coverage Outperform
(N/A)
2.56
(1.75)
-31.64% Details
6/1/2020 Aerie Pharma AERI New Coverage Outperform
(N/A)
14.03
(12.94)
-7.77% Details